Varaico: Literature-Extracted Genetic Variants

Gene:POLA2
Variant:p.G583R
Back to variants list

POLA2

NM_002689.4:p.G583R

Associated Papers

Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy.

Limviphuvadh V et al.

Bmc Cancer, 2018

The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.

Tang X et al.

Nucleic Acids Research, 2014

25352556 (PubMed )
Supplement: supp_gku1005_nar-01266-met-n-2014-File012.xlsx › TCGA-A2-A0ER-01A.domain

Novel SNP improves differential survivability and mortality in non-small cell lung cancer patients.

Mah TL et al.

Bmc Genomics, 2014

Genetic determinants of cancer drug efficacy and toxicity: practical considerations and perspectives.

Candelaria M et al.

Anti-cancer Drugs, 2005

Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathway.

Fukunaga AK et al.

The Pharmacogenomics Journal, 2004

Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients.

Wong AL et al.

Cancer Genomics & Proteomics, 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."